Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. (ORMP) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ORMP · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Oramed Pharmaceuticals Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ORMP insider buying and selling by quarter
ORMP insider selling · ORMP insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · ORMP ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ORMP executive sell shares · ORMP board member insider trading · ORMP insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 30, 2026 | KIDRON NADAV President and CEO · Director | Other | 44,818 | $148K | Form 4 |
| Mar 30, 2026 | Kidron Miriam Chief Scientific Officer · Director | Other | 435,084 | $1.44M⚡ | Form 4 |
| Mar 17, 2026 | Kidron Miriam Chief Scientific Officer · Director | Award | 119,558 | — | Form 4 |
| Mar 17, 2026 | KIDRON NADAV President and CEO · Director | Award | 167,005 | — | Form 4 |
| Mar 17, 2026 | Hexter Joshua COO & CBO | Award | 95,889 | — | Form 4 |
| Mar 17, 2026 | Gabay Avraham CFO | Award | 95,889 | — | Form 4 |
| Mar 12, 2026 | KIDRON NADAV President and CEO · Director | Gift | 100,000 | — | Form 4 |
| Jan 22, 2026 | Hexter Joshua COO & CBO | Option | 19,000 | — | Form 4 |
| Jan 22, 2026 | Kidron Miriam Chief Scientific Officer · Director | Option | 19,000 | — | Form 4 |
| Jan 22, 2026 | Gabay Avraham CFO | Option | 19,000 | — | Form 4 |
| Jan 22, 2026 | KIDRON NADAV President and CEO · Director | Option | 109,000 | — | Form 4 |
| Jan 14, 2026 | Kidron Miriam Chief Scientific Officer · Director | Gift | 86,166 | — | Form 4 |
| Dec 31, 2025 | Reznick Yehuda Director | Award | 6,250 | — | Form 4 |
| Dec 31, 2025 | Reznick Yehuda Director | Award | 30,000 | $360 | Form 4 |
| Dec 31, 2025 | KIDRON NADAV President and CEO · Director | Award | 327,000 | — | Form 4 |
| Dec 31, 2025 | KIDRON NADAV President and CEO · Director | Award | 232,640 | — | Form 4 |
| Dec 31, 2025 | Kidron Miriam Chief Scientific Officer · Director | Award | 115,000 | — | Form 4 |
| Dec 31, 2025 | Kidron Miriam Chief Scientific Officer · Director | Award | 121,331 | — | Form 4 |
| Dec 31, 2025 | Hexter Joshua COO & CBO | Award | 115,000 | — | Form 4 |
| Dec 31, 2025 | Hexter Joshua COO & CBO | Award | 97,328 | — | Form 4 |
| Dec 31, 2025 | Shapiro Benjamin Director | Award | 3,500 | — | Form 4 |
| Dec 31, 2025 | Shapiro Benjamin Director | Award | 30,000 | $360 | Form 4 |
| Dec 31, 2025 | Mayer Arie Director | Award | 4,900 | — | Form 4 |
| Dec 31, 2025 | Mayer Arie Director | Award | 30,000 | $360 | Form 4 |
| Dec 31, 2025 | Aghion Daniel Director | Award | 6,250 | — | Form 4 |
KIDRON NADAV
President and CEO · Director
Date
Mar 30
Shares
44,818
Price
$3.31
Value
$148K
Kidron Miriam
Chief Scientific Officer · Director
Date
Mar 30
Shares
435,084
Price
$3.31
Value
$1.44M ⚡
Kidron Miriam
Chief Scientific Officer · Director
Date
Mar 17
Shares
119,558
Price
—
Value
—
KIDRON NADAV
President and CEO · Director
Date
Mar 17
Shares
167,005
Price
—
Value
—
KIDRON NADAV
President and CEO · Director
Date
Mar 12
Shares
100,000
Price
—
Value
—
Kidron Miriam
Chief Scientific Officer · Director
Date
Jan 22
Shares
19,000
Price
—
Value
—
KIDRON NADAV
President and CEO · Director
Date
Jan 22
Shares
109,000
Price
—
Value
—
Kidron Miriam
Chief Scientific Officer · Director
Date
Jan 14
Shares
86,166
Price
—
Value
—
KIDRON NADAV
President and CEO · Director
Date
Dec 31
Shares
327,000
Price
—
Value
—
KIDRON NADAV
President and CEO · Director
Date
Dec 31
Shares
232,640
Price
—
Value
—
Kidron Miriam
Chief Scientific Officer · Director
Date
Dec 31
Shares
115,000
Price
—
Value
—
Kidron Miriam
Chief Scientific Officer · Director
Date
Dec 31
Shares
121,331
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ORMP insider trading
ORMP insider trades
Oramed Pharmaceuticals Inc. (ORMP) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including KIDRON NADAV (President and CEO · Director), Kidron Miriam (Chief Scientific Officer · Director), Hexter Joshua (COO & CBO). Over the past 12 months, 5 insiders have filed transactions with the SEC. ORMP insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Oramed Pharmaceuticals Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ORMP insider trading · 5 questionsThe insiders of Oramed Pharmaceuticals Inc. (ORMP) include executives and directors such as KIDRON NADAV (President and CEO · Director), Kidron Miriam (Chief Scientific Officer · Director), Hexter Joshua (COO & CBO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026